维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="Teachey"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Rapamycin improves lympho- proliferative disease in murine autoimmune lymphoproliferative syn- drome (ALPS) 显示文摘	Teachey DT Obzut DA Axsom K	2006	Blood2006，108，6：	1
2	Roles of insulin signaling and p38 MAPK in the activation by lithium of glucose transport in insulin resistant rat skeletal muscle显示文摘	Macko AR Beneze AN Teachey M	2008	Arch Physiol Biochem2008，114，5：	1
3	The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL显示文摘	David T Teachey Obzut DA	2006	Blood2006，107，3：	1
4	In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonu- cleotides显示文摘	Fujii H Trudeau JD Teachey DT	2007	Blood2007，109，5：	1
5	Use of fituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis显示文摘	Balamuth NJ Nichols KE Paessler M Teachey DT	2007	J Pediatr Hematol Oncol2007，，29：	1
6	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy显示文摘	Teachey DT Rheingold SR Maude SL	2013	Blood2013，121，：	1
7	The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL显示文摘	Teachey DT Obzut DA Cooperman J		0，，：	1
8	Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens 显示文摘	Chellapandian D Das R Zelley K Wiener SJ Zhao H Teachey DT Nichols KE EBV-HLH Rituximab Study Group	2013	Br J Haematol2013，162，3：	1
9	Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia显示文摘	Kathryn G. Roberts Ryan D. Morin Jinghui Zhang Martin Hirst Yongjun Zhao Xiaoping Su Shann-Ching Chen Debbie Payne-Turner Michelle L. Churchman Richard C. Harvey Xiang Chen Corynn Kasap Chunhua Yan Jared Becksfort Richard P. Finney David T. Teachey Shanno	2012	Cancer Cell2012，，2：	1
10	Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats显示文摘	Henriksen EJ Kinnick TR Teachey MK	2003	Am J Physiol Endocrinol Metab2003，284，5：	1
11	Unmasking Ev-ans syndrome:T-cell phenotype and apoptotic response re-veal autoimmune lymphoproliferative syndrome(ALPS)显示文摘	Teachey DT Manno CS Axsom KM	2005	Blood2005，105，6：	1
12	Managing cytokine release syndrome associated with novel T cell-engaglng therapies 显示文摘	Maude SL Barrett D Teachey DT	2014	Cancer J2014，20，2：	1
13	Daclizumab for children with corticosteroid refractory graft-versus-host disease 显示文摘	Teachey DT Bickert B Bunin N	2006	Bone Marrow Transplant2006，37，1：	1
14	Essential role of p38 MAPK for activation of skeletal muscle glucose transport by lithium 显示文摘	Harrell NB Teachey MK Gifford NJ	2007	Arch Physiol Biochem2007，113，4：	1
15	The roTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL显示文摘	Teachey DT Obzut DA Cooperman J	2006	Blood2006，107，3：	1
16	Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)显示文摘	Teachey DT Seif AE Grupp SA	2010	Br J Haematol2010，148，：	1
17	Modulation of muscle insulin resistance by selective glycogen synthase kinase-3 inhibition in Zucker diabetic fatty rats显示文摘	HENRIKSEN E J KINNICK T R TEACHEY M K		0，，05：	1
18	Targeting Notch signaling in autoimmune and lymphoproliferative disease 显示文摘	Teachey DT Seif AE Brown VI	2008	Blood2008，111，2：	1
19	The mTOR in hibitor CCI-779 induces apoptosis and inhibits growth in pre clinical models of primary adult human ALL显示文摘	Teachey DT Obzut DA Cooperman J	2006	Blood2006，1，3：	1
20	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy 显示文摘	Teachey DT Rheingold SR Maude SL	2013	Blood2013，121，26：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示